James Shepherd
Impact in
- Endocrinology, Diabetes and Metabolism top 0.02%
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Surgery top 0.01%
- Lipoproteins and Cardiovascular Health
Papers in
- Surgery 119
- Lipoproteins and Cardiovascular Health 111
- Cholesterol and Lipid Metabolism 16
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 65
- Co-authors
- Christopher J. Packard (61 shared papers)Ian Ford (30 shared papers)Stuart M. Cobbe (18 shared papers)Peter W. Macfarlane (16 shared papers)Antonio M. Gotto (18 shared papers)John J.P. Kastelein (14 shared papers)A R Lorimer (5 shared papers)James H. McKillop (3 shared papers)
- Journals
- Atherosclerosis (20 papers)The American Journal of Cardiology (10 papers)Circulation (9 papers)The Lancet (8 papers)Biochemical Society Transactions (8 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
James Shepherd
172 papers receiving 31.4k citations
James Shepherd's Hit Papers
Peers
Comparison fields: 5 of 184
- Endocrinology, Diabetes and Metabolism 11.0k
- Surgery 19.9k
- Cardiology and Cardiovascular Medicine 8.3k
- Cancer Research 4.2k
- Economics and Econometrics 5.8k
Countries citing papers authored by James Shepherd
This map shows the geographic impact of James Shepherd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Shepherd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Shepherd more than expected).
Fields of papers citing papers by James Shepherd
This network shows the impact of papers produced by James Shepherd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Shepherd. The network helps show where James Shepherd may publish in the future.
Co-authors
The 25 scholars most cited alongside James Shepherd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 175 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia Hit paper breakdown → | 1995 | 5775 |
| 2 | Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein Hit paper breakdown → | 2008 | 4712 |
| 3 | Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein Hit paper breakdown → | 2009 | 2948 |
| 4 | Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease Hit paper breakdown → | 2005 | 2485 |
| 5 | Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial Hit paper breakdown → | 2002 | 2393 |
| 6 | Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study Hit paper breakdown → | 2003 | 1200 |
| 7 | Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial Hit paper breakdown → | 2009 | 751 |
| 8 | Plasma Leptin and the Risk of Cardiovascular Disease in the West of Scotland Coronary Prevention Study (WOSCOPS) Hit paper breakdown → | 2001 | 689 |
| 9 | Pravastatin and the Development of Diabetes Mellitus Hit paper breakdown → | 2001 | 667 |
| 10 | Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study Hit paper breakdown → | 2007 | 572 |
| 11 | A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism Hit paper breakdown → | 2009 | 543 |
| 12 | Effects of Dietary Polyunsaturated and Saturated Fat on the Properties of High Density Lipoproteins and the Metabolism of Apolipoprotein A-I Hit paper breakdown → | 1978 | 387 |
| 13 | 2008 | 357 | |
| 14 | 2006 | 354 | |
| 15 | 1997 | 338 | |
| 16 | 2004 | 316 | |
| 17 | 2007 | 303 | |
| 18 | 2000 | 296 | |
| 19 | 1980 | 287 | |
| 20 | 2006 | 277 |
About James Shepherd
James Shepherd is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism, Economics and Econometrics, Cancer Research and Cardiology and Cardiovascular Medicine, having authored 175 papers that have together received 33.0k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (111 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (65 papers), Health Systems, Economic Evaluations, Quality of Life (32 papers), Cancer, Lipids, and Metabolism (31 papers), Cholesterol and Lipid Metabolism (16 papers), Pharmaceutical Economics and Policy (16 papers), Adipokines, Inflammation, and Metabolic Diseases (13 papers) and Lipid metabolism and disorders (12 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (11.0k citations), Surgery (19.9k citations), Cardiology and Cardiovascular Medicine (8.3k citations), Cancer Research (4.2k citations) and Economics and Econometrics (5.8k citations). James Shepherd has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Christopher J. Packard, Ian Ford, Stuart M. Cobbe, Peter W. Macfarlane, Antonio M. Gotto, John J.P. Kastelein, A R Lorimer, James H. McKillop, Christopher Isles and Chris J. Packard. Their work appears in journals such as Atherosclerosis, The American Journal of Cardiology, Circulation, The Lancet and Biochemical Society Transactions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.